Genzyme gets grant for method for reducing interference in drug assay due to antibodies
According to GlobalData’s company profile on Genzyme, was a key innovation area identified from patents. Genzyme's grant share as of February 2024 was 61%. Grant share is based on the ratio of number of grants to total number of patents. Method for …